199 related articles for article (PubMed ID: 9639039)
1. Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome.
Sharif K; Goyal M; Kershaw D; Kunkel R; Wiggins R
Exp Nephrol; 1998; 6(3):234-44. PubMed ID: 9639039
[TBL] [Abstract][Full Text] [Related]
2. Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis.
Hirakawa M; Tsuruya K; Yotsueda H; Tokumoto M; Ikeda H; Katafuchi R; Fujimi S; Hirakata H; Iida M
Life Sci; 2006 Jul; 79(8):757-63. PubMed ID: 16564554
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
Yang Y; Gubler MC; Beaufils H
Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
[TBL] [Abstract][Full Text] [Related]
4. Glomerular epithelial protein 1 and podocalyxin-like protein 1 in inflammatory glomerular disease (crescentic nephritis) in rabbit and man.
Yang DH; Goyal M; Sharif K; Kershaw D; Thomas P; Dysko R; Wiggins R
Lab Invest; 1996 Mar; 74(3):571-84. PubMed ID: 8600307
[TBL] [Abstract][Full Text] [Related]
5. Podocyte proteins in Galloway-Mowat syndrome.
Srivastava T; Whiting JM; Garola RE; Dasouki MJ; Ruotsalainen V; Tryggvason K; Hamed R; Alon US
Pediatr Nephrol; 2001 Dec; 16(12):1022-9. PubMed ID: 11793093
[TBL] [Abstract][Full Text] [Related]
6. GLEPP1 receptor tyrosine phosphatase (Ptpro) in rat PAN nephrosis. A marker of acute podocyte injury.
Kim YH; Goyal M; Wharram B; Wiggins J; Kershaw D; Wiggins R
Nephron; 2002 Apr; 90(4):471-6. PubMed ID: 11961407
[TBL] [Abstract][Full Text] [Related]
7. Synaptopodin expression in idiopathic nephrotic syndrome of childhood.
Srivastava T; Garola RE; Whiting JM; Alon US
Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, expression, and distribution of glomerular epithelial protein 1 in developing mouse kidney.
Wang R; St John PL; Kretzler M; Wiggins RC; Abrahamson DR
Kidney Int; 2000 May; 57(5):1847-59. PubMed ID: 10792603
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
10. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
11. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
[TBL] [Abstract][Full Text] [Related]
12. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Kitano Y; Yoshikawa N; Nakamura H
Clin Nephrol; 1993 Oct; 40(4):199-204. PubMed ID: 8261675
[TBL] [Abstract][Full Text] [Related]
13. GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase. Identification, molecular cloning, and characterization in rabbit.
Thomas PE; Wharram BL; Goyal M; Wiggins JE; Holzman LB; Wiggins RC
J Biol Chem; 1994 Aug; 269(31):19953-62. PubMed ID: 7519601
[TBL] [Abstract][Full Text] [Related]
14. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis.
Regele HM; Fillipovic E; Langer B; Poczewki H; Kraxberger I; Bittner RE; Kerjaschki D
J Am Soc Nephrol; 2000 Mar; 11(3):403-412. PubMed ID: 10703664
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning of cDNAs encoding human GLEPP1, a membrane protein tyrosine phosphatase: characterization of the GLEPP1 protein distribution in human kidney and assignment of the GLEPP1 gene to human chromosome 12p12-p13.
Wiggins RC; Wiggins JE; Goyal M; Wharram BL; Thomas PE
Genomics; 1995 May; 27(1):174-81. PubMed ID: 7665166
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic significance of glomerular epithelial cell vacuolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: an ultrastructural study.
Chiang ML; Hawkins EP; Berry PL; Barrish J; Hill LL
Clin Nephrol; 1988 Jul; 30(1):8-14. PubMed ID: 3061695
[TBL] [Abstract][Full Text] [Related]
17. Electron microscopic findings suggestive of focal and segmental glomerulosclerosis in patients with steroid-resistant nephrotic syndrome.
Nili F; Saboori F; Jahanzad I; Mehrazma M
Ultrastruct Pathol; 2019; 43(1):6-12. PubMed ID: 30835594
[TBL] [Abstract][Full Text] [Related]
18. The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.
McAdams AJ; Valentini RP; Welch TR
Medicine (Baltimore); 1997 Jan; 76(1):42-52. PubMed ID: 9064487
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
[TBL] [Abstract][Full Text] [Related]
20. Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate.
Wharram BL; Goyal M; Gillespie PJ; Wiggins JE; Kershaw DB; Holzman LB; Dysko RC; Saunders TL; Samuelson LC; Wiggins RC
J Clin Invest; 2000 Nov; 106(10):1281-90. PubMed ID: 11086029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
